HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P G Steg Selected Research
P G Steg Research Topics
Disease
11
Myocardial Infarction
11/2020 - 06/2000
7
Hemorrhage
11/2020 - 08/2006
6
Acute Coronary Syndrome
11/2020 - 11/2001
4
Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 03/2001
4
Coronary Artery Disease (Coronary Atherosclerosis)
10/2020 - 11/2000
4
Thrombosis (Thrombus)
09/2015 - 03/2007
4
ST Elevation Myocardial Infarction
09/2013 - 08/2006
4
Infarction (Infarctions)
03/2007 - 02/2001
3
Heart Failure
10/2015 - 03/2001
2
Peripheral Arterial Disease
10/2020 - 06/2010
2
Stroke (Strokes)
10/2020 - 08/2009
2
Diabetes Mellitus
10/2015 - 07/2013
2
Left Ventricular Dysfunction
02/2011 - 01/2008
2
Pathologic Constriction (Stenosis)
03/2007 - 06/2000
2
Hyperplasia
06/2001 - 02/2000
1
Anemia
11/2020
1
Non-ST Elevated Myocardial Infarction
11/2020
1
Vascular Diseases (Vascular Disease)
01/2019
1
Type 2 Diabetes Mellitus (MODY)
07/2013
1
Albuminuria
07/2013
1
Diabetic Retinopathy (Retinopathy, Diabetic)
07/2013
1
Inflammation (Inflammations)
07/2013
1
Insulin Resistance
07/2013
1
Ventricular Remodeling
02/2011
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2010
1
Heart Arrest (Cardiac Arrest)
02/2007
1
Hypertension (High Blood Pressure)
08/2006
1
Cardiomyopathies (Cardiomyopathy)
09/2004
1
Pheochromocytoma
09/2004
1
Angina Pectoris
03/2001
1
Myocarditis (Carditis)
03/2001
1
Atherosclerotic Plaque (Atheroma)
02/2000
1
Stable Angina
02/2000
Drug/Important Bio-Agent (IBA)
4
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
10/2020 - 11/2000
3
omega-Chloroacetophenone (Mace)
IBA
01/2021 - 10/2011
3
Anticoagulants
IBA
10/2020 - 08/2006
3
Ivabradine
IBA
09/2013 - 01/2008
2
Heparin (Liquaemin)
FDA Link
Generic
11/2020 - 08/2006
2
saxagliptin
FDA Link
10/2015 - 07/2013
2
Glycoproteins (Glycoprotein)
IBA
02/2008 - 08/2006
2
Fibrinolytic Agents (Antithrombotic Agents)
IBA
12/2007 - 04/2001
2
Creatinine
IBA
02/2007 - 08/2006
2
Abciximab (ReoPro)
FDA Link
02/2003 - 11/2001
1
Hemoglobins (Hemoglobin)
IBA
11/2020
1
Troleandomycin (TAO)
FDA Link
11/2020
1
otamixaban
IBA
11/2020
1
Eptifibatide (Integrilin)
FDA Link
11/2020
1
Rivaroxaban
IBA
10/2020
1
Antiphospholipid Antibodies
IBA
09/2015
1
Insulin (Novolin)
FDA Link
07/2013
1
Biomarkers (Surrogate Marker)
IBA
07/2013
1
Dipeptidyl-Peptidase IV Inhibitors
IBA
07/2013
1
Clopidogrel (Plavix)
FDA Link
10/2011
1
Aryldialkylphosphatase (Paraoxonase)
IBA
10/2011
1
Cytochrome P-450 CYP2C19
IBA
10/2011
1
Pharmaceutical Preparations
IBA
01/2011
1
Antihypertensive Agents (Antihypertensives)
IBA
06/2010
1
N 30
IBA
08/2009
1
Platelet Membrane Glycoprotein IIb
IBA
02/2008
1
Fibrin
IBA
12/2007
1
Coenzyme A (CoA)
IBA
08/2006
1
Biological Products
IBA
09/2004
1
Adrenergic Agents (Adrenergic Drugs)
IBA
09/2004
1
Lipids
IBA
07/2002
1
Platelet Glycoprotein GPIIb-IIIa Complex
IBA
11/2001
1
Thallium-201
IBA
03/2001
1
Indium-111
IBA
03/2001
1
Trimetazidine (Vastarel)
IBA
02/2001
1
Myoglobin
IBA
02/2001
1
Interleukin-10 (Interleukin 10)
IBA
02/2000
1
Phosphatidylserines
IBA
02/2000
1
Cytokines
IBA
02/2000
Therapy/Procedure
5
Percutaneous Coronary Intervention
09/2013 - 08/2005
5
Stents
03/2007 - 02/2000
4
Therapeutics
10/2020 - 02/2001
2
Secondary Prevention
01/2019 - 07/2002
2
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2007 - 03/2001
1
Blood Transfusion (Blood Transfusions)
11/2020
1
Duration of Therapy
09/2015
1
Surgical Amputation (Amputations)
07/2013
1
Treatment Delay
12/2007
1
Thrombolytic Therapy
12/2007
1
Drug-Eluting Stents
03/2007
1
Myocardial Revascularization
03/2002